Literature DB >> 25085204

Endothelin and vascular remodelling in colitis pathogenesis--appendicitis and appendectomy limit colitis by suppressing endothelin pathways.

Rajkumar Cheluvappa1, Rajaraman Eri, Annie S Luo, Michael C Grimm.   

Abstract

PURPOSE: Appendicitis and appendectomy(AA), when done at a young age, offer protection against inflammatory bowel disease (IBD) development in later life. However, IBD pathogenesis involves both immunological and vascular abnormalities. Using the first murine model of AA (developed by us), we aimed to determine the role of AA in modulating vascular remodelling mediated by endothelin activity in IBD.
METHODS: Mice with two laparotomies each served as controls (sham-sham or SS). Distal colons were harvested (four AA group colons, four SS group colons), and RNA extracted from each. The RNA was subjected to microarray analysis and RT-PCR validation. Gene set enrichment analysis (GSEA) software was used to further analyze the microarray data.
RESULTS: Gene expression of seven genes closely associated with endothelin activity was examined in distal colons 3 days post-AA and 28 days post-AA. While there were no gene expression changes 3 days post-AA, the genes EDN1 (0.7-fold), EDN2 (0.8-fold) and ECE2 (0.8-fold) were downregulated (*p value <0.05) 28 days post-AA. However, EDN3 (1.3-fold) was upregulated 28 days post-AA (*p value <0.05). GSEA analysis showed downregulation of 11 gene sets (stringent cut-offs-false discovery rate <5 % and p value <0.001) associated with endothelin and endothelin-converting enzyme genes by AA, in contrast to only 1 being upregulated.
CONCLUSIONS: AA induces a delayed but significant suppression of genes pertaining to endothelin activity. Elucidating the pathways involved in suppression of endothelin activity and manipulation of different genes/enzymes/proteins related to endothelin activity will significantly enhance the extant repertoire of therapeutic options in IBD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25085204     DOI: 10.1007/s00384-014-1974-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  36 in total

Review 1.  Endothelin peptides: biological activities, cellular signalling and clinical significance.

Authors:  J Leppäluoto; H Ruskoaho
Journal:  Ann Med       Date:  1992-06       Impact factor: 4.709

2.  High endothelin-1 immunoreactivity in Crohn's disease and ulcerative colitis.

Authors:  S H Murch; C P Braegger; W C Sessa; T T MacDonald
Journal:  Lancet       Date:  1992-02-15       Impact factor: 79.321

Review 3.  Endothelin Converting Enzyme-1 phosphorylation and trafficking.

Authors:  Sanjaya Kuruppu; A Ian Smith
Journal:  FEBS Lett       Date:  2012-06-21       Impact factor: 4.124

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Role of endothelins in trinitrobenzene sulfonic acid-induced colitis in rats.

Authors:  B M Güllüoglu; H Kurtel; M G Güllüoglu; C Yegen; A O Aktan; F Dizdaroglu; R Yalin; B C Yegen
Journal:  Digestion       Date:  1999 Sep-Oct       Impact factor: 3.216

6.  Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2.

Authors:  A P Davenport; R E Kuc
Journal:  J Cardiovasc Pharmacol       Date:  2000-11       Impact factor: 3.105

7.  Localisation of endothelin B receptor variants to plasma membrane microdomains and its effects on downstream signalling.

Authors:  Solveig Grossmann; Shigeki Higashiyama; Alexander Oksche; Michael Schaefer; Astrid Tannert
Journal:  Mol Membr Biol       Date:  2009-08       Impact factor: 2.857

8.  A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels.

Authors:  M Yanagisawa; H Kurihara; S Kimura; K Goto; T Masaki
Journal:  J Hypertens Suppl       Date:  1988-12

9.  Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.

Authors:  C Letizia; M Boirivant; G De Toma; S Cerci; S Subioli; L Scuro; P Ferrari; F Pallone
Journal:  Ital J Gastroenterol Hepatol       Date:  1998-06

10.  Minimum Information About a Microarray Experiment (MIAME)--successes, failures, challenges.

Authors:  Alvis Brazma
Journal:  ScientificWorldJournal       Date:  2009-05-29
View more
  4 in total

1.  Inflammatory bowel disease: Traditional knowledge holds the seeds for the future.

Authors:  Giovanni C Actis; Rinaldo Pellicano; Floriano Rosina
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-05-06

2.  Potential role for ET-2 acting through ETA receptors in experimental colitis in mice.

Authors:  R F Claudino; D F Leite; A F Bento; J G Chichorro; J B Calixto; G A Rae
Journal:  Inflamm Res       Date:  2016-10-24       Impact factor: 4.575

3.  A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages.

Authors:  Camille Danne; Grigory Ryzhakov; Maria Martínez-López; Nicholas Edward Ilott; Fanny Franchini; Fiona Cuskin; Elisabeth C Lowe; Samuel J Bullers; J Simon C Arthur; Fiona Powrie
Journal:  Cell Host Microbe       Date:  2017-12-13       Impact factor: 21.023

4.  The Role of Specific Chemokines in the Amelioration of Colitis by Appendicitis and Appendectomy.

Authors:  Rajkumar Cheluvappa; Dennis G Thomas; Selwyn Selvendran
Journal:  Biomolecules       Date:  2018-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.